prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, DIAGNOSIS. (A) SENTINEL LYMPH NODE #1, LEFT AXILLA, BIOPSY: One lymph node, free of tumor. (See Comment). (B) SENTINEL LYMPH NODE #2, LEFT AXILLA, BIOPSY: One lymph node, free of tumor. (See Comment). (C) LEFT BREAST, NEEDLE LOCALIZATION SEGMENTAL MASTECTOMY: INVASIVE DUCTAL CARCINOMA OF BREAST, MODIFIED BLACK'S NUCLEAR GRADE 3 (POORLY. DIFFERENTIATED). INVASIVE CARCINOMA MEASURES 1.2 CM IN GREATEST DIMENSION. Lymphatic/vascular invasion is not identified. INTRADUCTAL CARCINOMA (DCIS), MODIFIED BLACK'S NUCLEAR GRADE 3 (POORLY DIFFERENTIATED),. COMPRISING SOLID TYPE, WITH NECROSIS, COMPRISING <5% OF THE TUMOR AREA. INVASIVE CARCINOMA EXTENDS TO WITHIN 5.0 MM OF THE NEAREST DEEP MARGIN. All margins are free of tumor. (D) LEFT BREAST, SECOND DEEP MARGIN, EXCISION: Skeletal muscle, no tumor present. (E) LEFT BREAST, SECOND MEDIAL MARGIN, EXCISION: No tumor present. (F) LEFT BREAST, SECOND SUPERIOR MARGIN, EXCISION: No tumor present. (G) LEFT BREAST, SECOND INFERIOR MARGIN: No tumor present. Entire report and diagnosis completed by v. OMMENT. Immunohistochemical stains for cytokeratins have been requested on tissue sections from both sentinel lymph nodes. Those. results will be reported as an addendum. Molecular pathologic assays have been requested on tissue sections from block C1 of. the primary tumor. Those results will be reported as an addendum. The invasive carcinoma measures 1.2 cm in greatest. microscopic diameter (slide C1) and focally invades pectoralis muscle, extending to within 5.0 mm of the deep margin (slide C2). GROSS DESCRIPTION. (A) LEFT AXILLA, SENTINEL LYMPH NODE BIOPSY #1, IN VIVO 216, EX VIVO 4 - A 0.8 x 0.6 x 0.4 cm lymph node. The. specimen is transected and two touch imprints were performed. The remnant of the tissue is submitted in toto in A. TP/DX: NO CARCINOMA IDENTIFIED. (B) LEFT AXILLA SENTINEL BIOPSY #2, IN VIVO 416, EX VIVO 887 - A 2.0 x 1.0 x 0.6 cm lymph node with surrounding fat. tissue. Specimen is bisected and two touch imprints are performed. A remnant of the lymph node is submitted in B1-B2. TP/DX: NO CARCINOMA IDENTIFIED. (C). LEFT NEEDLE LOCALIZATION, SEGMENTAL MASTECTOMY - A segmental mastectomy specimen (7.0 x 7.0 x 4.0 cm). with a skin ellipse (2.8 x 1.2 cm). The specimen has two clips indicating anterior aspect and one clip indicating the middle aspect. The. specimen is serially sectioned from medial to lateral. The cut surface shows an ill-defined, white-firm lesion measuring 0.8 x. 6 x 0.6 cm that is 0.7 cm from the deep margin. The remnant of the breast tissue is predominantly composed of fatty tissue. INK CODE: Green - inferior; blue - superior; black - deep; yellow - superficial; red - lateral; orange - medial. SECTION CODE: C1-C2, tumor in relation to the deep margin; C3, extra section from the tumor; C4-C5, random section. from the breast including the skin. (D). SECOND. DEEP MARGIN, CLIP ON TRUE MARGIN - An oriented irregular fragment of skeletal muscle measuring 3.0 x 1.5 x. 5 cm. The specimen is oriented as clip on true margin. The true margin is inked in black. The specimen is serially sectioned and. entirely submitted in D1-D2. (E). SECOND MEDIAL MARGIN, CLIP ON TRUE MARGIN - An oriented irregular fragment of adipose tissue measuring 4.0 x 2.0. x. 0.8. cm. The. specimen. is. oriented as clip on true margin. The true margin is inked in black. The specimen is serially sectioned. and entirely submitted in E1-E4. (F) SECOND SUPERIOR MARGIN, CLIP ON TRUE MARGIN - An oriented irregular fragment of adipose tissue measuring 3.5 x. 2.0 x 0.8 cm. The specimen is oriented as clip on true margin. The true margin is inked in black. The specimen is serially. sectioned and entirely submitted in F1-F3. is oriented as clip on true margin. The true margin is inked in black. The specimen is serially sectioned and entirely submitted in. (G). SECOND. INFERIOR MARGIN - An oriented irregular fragment of adipose tissue measuring 3.5 x 2.5 x 0.6 cm. The specimen. G1-G3. I. CLINICAL HISTORY. Left breast cancer. SNOMED CODES. T-04050, M-85003, M-85002, T-C4714, M-00110. "Some tests reported here may have been developed and performance characteristics determined by. These tests have not been specifically cleared or approved by the U.S. Food and Drug Administration. Released by: Start of ADDENDUM. ADDENDUM. Addendum completed by .. COMMENT. Immunohistochemical stains for cytokeratin were reviewed on tissue sections from both sentinel lymph nodes and were negative. Released by: Start of ADDENDUM #2. ADDENDUM. Addendum completed by ,. This report is issued to give immunohistochemistry results. Immunohistochemical staining is performed on a representative section of INVASIVE DUCTAL CARCINOMA, left breast, block. C1. MARKER. % POSITIVE. STAINING. INTENSITY. Estrogen Receptor. Positive. 100 %. CC # 52. Progesterone Receptor. Positive. 90 %. C-erbB-2 (HER-2/neu). overexpression. Negative. 0%. 0. Ki-67. High (>35%). 50 %. N/A. FOOTNOTE. Estrogen receptor was assessed by immunohistochemistry using antibody 6F11 (. Progesterone receptor was assessed by immunohistochemistry using antibody 1A6. c-erbB-2 (HER-2/neu) was assessed by immunohistochemistry using antibody AB8. Ki-67 was assessed by immunohistochemistry using antibody MIB1. Released by:

expanded version (tokens=1921) : 
 The breast pathology report includes information on the lymph nodes, the left breast, and ancillary testing results. Here are the main points of the report:

- Lymph nodes: Two sentinel lymph nodes in the left axilla were biopsied and found to be free of tumor.
- Left breast: The report indicates the presence of invasive ductal carcinoma (IDC) of the breast, with modified Black's nuclear grade 3 (poorly differentiated). The invasive carcinoma measures 1.2 cm in greatest dimension and was found to extend to within 5.0 mm of the nearest deep margin. Lymphatic/vascular invasion was not identified. Intraductal carcinoma (DCIS) was also found, with modified Black's nuclear grade 3 (poorly differentiated), comprising solid type, with necrosis, comprising <5% of the tumor area. All margins are free of tumor.
- Histological classification: The subtype identified is LumA.
- Histological grade: The IDC is described as modified Black's nuclear grade 3 (poorly differentiated).
- Necrosis: Necrosis was present in the DCIS component of the tumor and comprised <5% of the tumor area.
- Tumor infiltrating lymphocytes: There is no mention of any tumor infiltrating lymphocytes.
- Receptor status: The report indicates that the estrogen receptor (ER) is positive in 100% of tumor cells, and the progesterone receptor (PR) is positive

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2091) : 
 The breast pathology report confirms a diagnosis of invasive ductal carcinoma (IDC) and intraductal carcinoma (DCIS), with necrosis comprising <5% of the tumor area in DCIS. The IDC is poorly differentiated with a subtype of LumA and measures 1.2cm in greatest dimension, invading pectoralis muscle, extending to within 5.0mm of the deep margin, but without lymphatic/vascular invasion. ER and PR receptors test positive in 100% and 90% tumor cells respectively on IHC testing, whereas HER-2/neu expression tests negative.

